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Adrenal insuﬃciency and liver disease – Re-searchpatients with end-stage liver disease and raised the ques-To the Editor:
It is always a debatable point whether there is much
diﬀerence between a paper rejected for publication ver-
sus the one published but rarely cited.
In a recent review on ‘‘Adrenal insuﬃciency and Liver
disease – what is the evidence?” [1] a relevant paper on the
topic [2] was ignored by the reviewerswho claimonly 5pa-
pers have been published on the topic in the literature.
Some 16 years ago, following clinical suspicion of func-
tional adrenal insuﬃciency in occasional patients with
end-stage cirrhosis, we embarked on a systematic study
of adrenal function in 51 consecutive adult patients with
end-stage non-alcoholic cirrhosis undergoing liver trans-
plant work-up. The study was restricted to those having
non-alcoholic liver disease in order to avoid the con-
founding eﬀects of alcohol on adrenocortical function.
Results were compared to 40 healthy controls. Compared
with healthy controls, patients had a 64% reduction in
maximal increments of plasma cortisol to indirect adrenal
stimulation via insulin-induced hypoglycaemia and a 39%
reduction to direct adrenal stimulation by ACTH (all
P < 0.001). There was a signiﬁcant negative correlation
between the severity of the underlying liver disease as as-
sessed by Child-Pugh scores and peak control response to
ACTH (r = 0.647,P < 0.0001) and insulin-induced hypo-
glycaemia (r = 0.597, P < 0.0001). Baseline morning
cortisol, free cortisol and dehydroepiandrosterone sulfate
levels were unchanged compared with healthy controls.
We concluded that hypothalamic–pituitary regulation
of adrenal function was signiﬁcantly blunted in end-stage
non-alcoholic liver disease.We postulated that functional
adrenal insuﬃciency might contribute to the mortality oftion of the need for controlled studies of adrenocortical
replacement therapy during acute deteriorations (sepsis
and haemorrhage) in severe hepatic disease. Thus, it
would not seem unreasonable for future authors who
tackle this subject to reference this publication. I also feel
that the authors should have also have referenced even
older studies going back as far as 1957 that seem some-
what relevant to the topic. (These studies are referenced
in our paper.) The term ‘‘re-search” is sometimes most
apt.
References
[1] O’ Beirne J, Holmes M, Agarwal B, Bouloux P, Shaw S, Patch D,
et al. Adrenal insuﬃciency in liver disease – what is the evidence? J
Hepatol 2007;47:418–423.
[2] McDonald JA, Handelsman DJ, Dilworth P, Conway A, McCau-
ghan GW. Hypothalamic–pituitary adrenal function in end stage
non-alcoholic liver disease. J Gastroenterol Hepatol
1993;8:247–253.
Geoﬀrey W. McCaughan
A.W. Morrow Gastroenterology and Liver Center,
Centenary Research Institute,
Royal Prince Alfred Hospital,
University of Sydney,
Sydney, Australia
E-mail address: g.mccaughan@centenary.usyd.edu.au
doi:10.1016/j.jhep.2008.03.005Incidence of adrenal dysfunction in cirrhosisTo the Editor:
We thank Professor McCaughan for his interest in
our review and his comments regarding the incidence
of adrenal dysfunction in cirrhosis. We apologise for
not citing his paper but we chose to focus on studies
of adrenal insuﬃciency in the setting of critical illness,as it is in this particular context that data pertaining
to adrenal insuﬃciency may lead to corticotherapy being
applied to patients with liver disease.
In our review we highlight the fact that although adre-
nal insuﬃciency is common in critically ill patients with
liver disease andmay be associatedwith aworse outcome,
